![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 292, Issue 2, 597-605, February 2000
Department of Pharmacology and Toxicology and Department of
Pathology, Michigan State University, East Lansing, Michigan (N.E.K.);
and Department of Biological Sciences, Korea Advanced Institute of
Science and Technology, Taejon, Korea (S.S.Y., K.-H.Y.).
We previously reported that immunosuppressive
cannabinoids inhibited interleukin (IL)-2 steady-state mRNA expression
and secretion by phorbol-12-myristate-13-acetate plus
ionomycin-activated mouse splenocytes and EL4 murine T-cells. Here we
show that inhibition of IL-2 production by cannabinol, a modest
central nervous system-active cannabinoid, is mediated through the
inhibition of IL-2 gene transcription. Moreover, electrophoretic
mobility shift assays demonstrated that cannabinol markedly inhibited
the DNA binding activity of nuclear factor of activated T-cells (NF-AT)
and activator protein-1 (AP-1) in a time- and concentration-dependent
manner in activated EL4 cells. The inhibitory effects produced by
cannabinol on AP-1 DNA binding were quite transient, showing partial
recovery by 240 min after cell activation and no effect on the activity
of a reporter gene under the control of AP-1. Conversely,
cannabinol-mediated inhibition of NF-AT was robust and sustained as
demonstrated by an NF-AT-regulated reporter gene. Collectively, these
results suggest that decreased IL-2 production by cannabinol in EL4
cells is due to the inhibition of transcriptional activation of the IL-2 gene and is mediated, at least in part, through a transient inhibition of AP-1 and a sustained inhibition of NF-AT.
This article has been cited by other articles:
|
|
 |
|
  H. Lu, B. L. F. Kaplan, T. Ngaotepprutaram, and N. E. Kaminski Suppression of T cell costimulator ICOS by {Delta}9-tetrahydrocannabinol J. Leukoc. Biol., February 1, 2009; 85(2): 322 - 329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Buchweitz, P. W. F. Karmaus, K. J. Williams, J. R. Harkema, and N. E. Kaminski Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of {Delta}9-tetrahydrocannabinol J. Leukoc. Biol., March 1, 2008; 83(3): 785 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. I. Marusina, S. J. Burgess, I. Pathmanathan, F. Borrego, and J. E. Coligan Regulation of Human DAP10 Gene Expression in NK and T Cells by Ap-1 Transcription Factors J. Immunol., January 1, 2008; 180(1): 409 - 417. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Rao and N. E. Kaminski Induction of intracellular calcium elevation by {Delta}9-tetrahydrocannabinol in T cells involves TRPC1 channels J. Leukoc. Biol., January 1, 2006; 79(1): 202 - 213. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhao, Z. He, N. Chen, Y.-Y. Cho, F. Zhu, C. Lu, W.-y. Ma, A. M. Bode, and Z. Dong 2-Arachidonoylglycerol Stimulates Activator Protein-1-dependent Transcriptional Activity and Enhances Epidermal Growth Factor-induced Cell Transformation in JB6 P+ Cells J. Biol. Chem., July 22, 2005; 280(29): 26735 - 26742. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. L. F. Kaplan, Y. Ouyang, C. E. Rockwell, G. K. Rao, and N. E. Kaminski 2-Arachidonoyl-glycerol suppresses interferon-{gamma} production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2 J. Leukoc. Biol., June 1, 2005; 77(6): 966 - 974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Rao, W. Zhang, and N. E. Kaminski Cannabinoid receptor-mediated regulation of intracellular calcium by {Delta}9-tetrahydrocannabinol in resting T cells J. Leukoc. Biol., May 1, 2004; 75(5): 884 - 892. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sancho, A. Macho, L. de La Vega, M. A. Calzado, B. L. Fiebich, G. Appendino, and E. Munoz Immunosuppressive Activity of Endovanilloids: N-Arachidonoyl-Dopamine Inhibits Activation of the NF-{kappa}B, NFAT, and Activator Protein 1 Signaling Pathways J. Immunol., February 15, 2004; 172(4): 2341 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, L. Nong, and H. Friedman The cannabinoid system and immune modulation J. Leukoc. Biol., October 1, 2003; 74(4): 486 - 496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. L. F. Kaplan, C. E. Rockwell, and N. E. Kaminski Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes J. Pharmacol. Exp. Ther., September 1, 2003; 306(3): 1077 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-R. Jan, G. K. Rao, and N. E. Kaminski Cannabinol Enhancement of Interleukin-2 (IL-2) Expression by T Cells Is Associated with an Increase in IL-2 Distal Nuclear Factor of Activated T Cell Activity Mol. Pharmacol., February 1, 2002; 61(2): 446 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. V. BERDYSHEV, P. C. SCHMID, R. J. KREBSBACH, and H. H. O. SCHMID Activation of PAF receptors results in enhanced synthesis of 2-arachidonoylglycerol (2-AG) in immune cells FASEB J, October 1, 2001; 15(12): 2171 - 2178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Chuang, H.-T. K. Pham, P. R. Kumaresan, and P. A. Mathew A Prominent Role for Activator Protein-1 in the Transcription of the Human 2B4 (CD244) Gene in NK Cells J. Immunol., May 15, 2001; 166(10): 6188 - 6195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-R. Jan and N. E. Kaminski Role of mitogen-activated protein kinases in the differential regulation of interleukin-2 by cannabinol J. Leukoc. Biol., May 1, 2001; 69(5): 841 - 849. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
